HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy.

AbstractAIM:
This study aimed to explore the role of the developed nomogram in the prognosis of esophageal squamous cell carcinoma (ESCC).
METHODS:
A total of 181 ESCC patients were randomly divided into a training cohort (n = 141) and a validation cohort (n = 40). Significant factors impacting overall survival (OS) were identified in the training set and integrated into the nomogram based on Cox proportional hazards regression.
RESULTS:
In the training cohort, the median OS in the high group (≥222) was 49.9 months and the median OS in the low group (<222) was 14.4 months. Multivariate analysis revealed that age, Karnofsky performance status score, tumor stage, chemotherapy, BMI, cervical esophageal carcinoma index and neutrophil to lymphocyte ratio were predictors of OS.
CONCLUSION:
The developed nomogram can effectively predict the survival prognosis of ESCC patients.
AuthorsLing Xiao, Jiahua Lyu, Meihua Chen, Liu Wang, Jing Huang, Yajun Wei, Tao Li
JournalFuture science OA (Future Sci OA) Vol. 8 Issue 3 Pg. FSO781 (Mar 2022) ISSN: 2056-5623 [Print] England
PMID35251695 (Publication Type: Journal Article)
Copyright© 2022 The Authors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: